Designed for enhanced visibility via CT scan
Visible on a CT scan, SpaceOAR Vue™ Hydrogel is designed to aid in visualization of the target region, enabling efficient patient positioning for radiation treatment.1 In Dr. Randall Brenneman’s and Dr. Brian Baumann’s experience, SpaceOAR Vue Hydrogel appears (or seems) to polymerize slightly slower compared to SpaceOAR “making it more forgiving with regards to suboptimal placement in the perirectal space.”2
SpaceOAR Vue Hydrogel could be a suitable imaging option for prostate cancer patients or patients with implanted metallic devices who cannot undergo an MRI. It may also reduce the need for post-implant MRI scans leading to cutting out-of-pocket costs for patients.1
Interested in streamlining your prostate cancer treatment planning?
Connect with our team to learn more about SpaceOAR Vue Hydrogel, schedule a demo, or get answers to your questions.
See how SpaceOAR Vue Hydrogel can benefit your patients and practice
Dr. Bill Johnson
Exeter Hospital, New Hampshire
“I think the paramount reason to use SpaceOAR Vue is an ability to view your results easily. It’s cost-effective for patients to get a post-procedural CT scan as opposed to an MRI.”
Reimbursement and Coding Guide
SpaceOAR Vue Hydrogel is covered and reimbursed by Medicare and the majority of the nation’s largest insurance plans. On average, the HOPD Medicare reimbursement has increased 6% year over year from 2018 to 2021. And with improved visibility on a CT scan, your team may avoid the time needed for MRI preauthorization.
Learn more about SpaceOAR Vue Hydrogel
Connect with our team for answers to your questions or to schedule a demo.
Get the latest clinical data, training materials, and more.
“When I have the iodinated spacer between the prostate and the rectum, it makes it really easy for me to delineate.”